New monthly shot could simplify diabetes care
NCT ID NCT07563699
First seen May 19, 2026 · Last updated May 25, 2026 · Updated 1 time
Summary
This study tests a new long-acting version of semaglutide (a diabetes drug) that is given once a month instead of weekly. It aims to see if it is safe and works well for controlling blood sugar and weight in 24 adults with type 2 diabetes. Participants must already be on weekly semaglutide and have stable blood sugar levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mapi pharma Investigational Site ISR001
Tel Aviv, 6423906, Israel
Conditions
Explore the condition pages connected to this study.